This Monday, May 15th, representatives from bioXclusters plus and Fenglin Group signed a Gateway Agreement to offer free services and guidance for SMEs in their operations in China. Services will include assistance in market access, private investment, clinical trials and soft landing packages. Continue reading
On 15th – 16th May bioXclusters plus will carry out a China Mission, bringing clusters and companies together at the Sino European Bio Partnering (SEBP) event at a reduced rate. Following bioXclusters plus strategy, the metacluster alliance will sign an MoU with Fenglin Group in order to provide guidance, consultancy and support to European life -sciences SMEs interested in doing business in China. Continue reading
The bioXclusters partners, along with some European SMEs, visited Shanghai in May 2013. Read the report about the mission which includes descriptions of the visits made and information about life sciences in this exciting and fast growing market.
On May 29th 2013, bioXclusters partners co-organised with G-Med consulting and the European cluster from Wallonia, the first edition of Sino-Europe Bio partnering (SEBP2013) which took place in Shanghai. The event was hosted by the Zhangjiang Hi-tech Park, the most advanced and largest life science park in China. Continue reading
Download the brochure which contains full details about the delegation that will travel to China from 27th to 31st May 2013. A total of 12 European companies will accompany the project partners.
The bioXclusters project partners are planning a trade mission to Shanghai (China) to learn mor about the life sciences sector in this country. The mission will take place from the 26th to the 31st May 2013 and plans to attend two events. All partners in the project as well as some companies located in the bioXcluster regions will take part in this mission. Continue reading
See this video about Mr. Gao Rohghui’s recent visit to Europe. It gives a great overview of what to do and what not to do when entering the Chinese life sciences market.